Sign inGet started

Novartis Institutes for BioMedical Research, Inc.

Insider CIK 1673852 · NTLA 10% owner · FIXX 10% owner · SURF 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
SURF Surface Oncology, Inc. C Conversion deriv2018-04-232018-04-231,571,429— $00SEC↗
SURF Surface Oncology, Inc. C Conversion deriv2018-04-232018-04-235,214,286— $00SEC↗
SURF Surface Oncology, Inc. C Conversion2018-04-232018-04-23909,090— $03,181,816SEC↗
SURF Surface Oncology, Inc. C Conversion2018-04-232018-04-232,272,726— $02,272,726SEC↗
SURF Surface Oncology, Inc. P Buy2018-04-232018-04-23766,666$15.00 $11.50M3,948,482SEC↗
FIXX Homology Medicines, Inc. C Conversion deriv2018-04-022018-04-041,979,226— $00SEC↗
FIXX Homology Medicines, Inc. C Conversion2018-04-022018-04-041,979,226— $01,979,226SEC↗
NTLA Intellia Therapeutics, Inc S Sale2017-12-122017-12-141,523,000$18.30 $27.87M4,129,903SEC↗
NTLA Intellia Therapeutics, Inc J Other2017-03-032017-03-0779,245— $05,652,903SEC↗
NTLA Intellia Therapeutics, Inc C Conversion deriv2016-05-112016-05-114,761,905— $00SEC↗
NTLA Intellia Therapeutics, Inc C Conversion deriv2016-05-112016-05-11761,905— $00SEC↗
NTLA Intellia Therapeutics, Inc C Conversion deriv2016-05-112016-05-112,666,666— $00SEC↗
NTLA Intellia Therapeutics, Inc C Conversion2016-05-112016-05-111,724,240— $04,803,241SEC↗
NTLA Intellia Therapeutics, Inc C Conversion2016-05-112016-05-11492,640— $05,295,881SEC↗
NTLA Intellia Therapeutics, Inc P Buy2016-05-112016-05-11277,777$18.00 $5.00M5,573,658SEC↗
NTLA Intellia Therapeutics, Inc C Conversion2016-05-112016-05-113,079,001— $03,079,001SEC↗